Immediate Impact
1 by Nobel laureates 62 standout
Citing Papers
Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial
2024 Standout
Cardiovascular benefits of SGLT2 inhibitors and GLP-1 receptor agonists through effects on mitochondrial function and oxidative stress
2024 Standout
Works of Yshai Yavin being referenced
Canagliflozin and Kidney-Related Adverse Events in Type 2 Diabetes and CKD: Findings From the Randomized CREDENCE Trial
2021
Effects of the SGLT2 inhibitor canagliflozin on plasma biomarkers TNFR-1, TNFR-2 and KIM-1 in the CANVAS trial
2021
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Yshai Yavin | 253 | 95 | 65 | 97 | 20 | 333 | |
| Susanne Jung | 180 | 78 | 162 | 67 | 30 | 343 | |
| Donna Shu‐Han Lin | 182 | 77 | 80 | 52 | 25 | 273 | |
| Bai Chang | 128 | 38 | 39 | 67 | 23 | 327 | |
| Anastasia Ustyugova | 266 | 78 | 110 | 93 | 31 | 369 | |
| Alain Gay | 171 | 81 | 137 | 49 | 21 | 338 | |
| Zhenwei Fang | 211 | 109 | 46 | 94 | 14 | 307 | |
| Maria Toumpourleka | 126 | 50 | 101 | 81 | 23 | 331 | |
| Sophie Girerd | 157 | 88 | 70 | 62 | 19 | 317 | |
| Takehiro Kawata | 180 | 51 | 33 | 77 | 14 | 364 | |
| A Okša | 82 | 28 | 68 | 49 | 20 | 328 |
All Works
Loading papers...